PHARMACIELO LTDPHARMACIELO LTDPHARMACIELO LTD

PHARMACIELO LTD

No trades
See on Supercharts
Next report date
Report period
EPS estimate
Revenue estimate
Market capitalization
‪11.53 M‬CAD
−0.085CAD
‪−16.30 M‬CAD
‪1.54 M‬CAD
‪158.15 M‬
Beta (1Y)
1.96

About PHARMACIELO LTD


CEO
Marc Lustig
Headquarters
Toronto
Founded
2014
FIGI
BBG00J4XKS34
PharmaCielo Ltd. operates as a pharmaceutical company. It engages in the processing and supplying all natural, medicinal-grade cannabis oil extracts, and related products to large channel distributors. The company was founded on July 14, 2014 and is headquartered in Toronto, Canada.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
Curated watchlists where PCLO is featured.

Frequently Asked Questions


The current price of PCLO is 0.085 CAD — it hasn't changed in the past 24 hours. Watch PHARMACIELO LTD stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on TSXV exchange PHARMACIELO LTD stocks are traded under the ticker PCLO.
PCLO stock has fallen by −22.73% compared to the previous week, the month change is a −22.73% fall, over the last year PHARMACIELO LTD has showed a −43.33% decrease.
PCLO reached its all-time high on Jan 22, 2019 with the price of 11.500 CAD, and its all-time low was 0.065 CAD and was reached on Nov 18, 2024. View more price dynamics on PCLO chart.
See other stocks reaching their highest and lowest prices.
PCLO stock is 12.50% volatile and has beta coefficient of 1.96. Track PHARMACIELO LTD stock price on the chart and check out the list of the most volatile stocks — is PHARMACIELO LTD there?
Yes, you can track PHARMACIELO LTD financials in yearly and quarterly reports right on TradingView.
PHARMACIELO LTD is going to release the next earnings report on May 5, 2025. Keep track of upcoming events with our Earnings Calendar.
PCLO net income for the last quarter is ‪−2.64 M‬ CAD, while the quarter before that showed ‪−2.58 M‬ CAD of net income which accounts for −2.66% change. Track more PHARMACIELO LTD financial stats to get the full picture.
No, PCLO doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. PHARMACIELO LTD EBITDA is ‪−5.61 M‬ CAD, and current EBITDA margin is −592.94%. See more stats in PHARMACIELO LTD financial statements.
Like other stocks, PCLO shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade PHARMACIELO LTD stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So PHARMACIELO LTD technincal analysis shows the sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating PHARMACIELO LTD stock shows the sell signal. See more of PHARMACIELO LTD technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.